Microtubule/Tubulin inhibitor, ABT-751, Purity ≥98%

Cat. No.: X24-08-YM213

Microtubule/Tubulin inhibitor, ABT-751, Purity ≥98%

Synonym: 141430-65-1; ABT751; E-7010; N-[2-(4-Hydroxyanilino)pyridin-3-yl]-4-methoxybenzenesulfonamide

  • MDL: MFCD00910291
  • CAS Number: 141430-65-1
  • Compound CID: 3035714
Product Size
10 mg; 50 mg; 100 mg; 200 mg
Price
Datasheet
MSDS
Properties
Description
ABT-751, soluble in DMSO and ethanol and insoluble in water, is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting microtubule/tubulin.
Molecular Weight
371.4
Molecular Formula
C18H17N3O4S
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO: 71 mg/mL (191.16 mM); Water: insoluble; Ethanol: 12 mg/mL (32.3 mM); In vivo: 30% propylene glycol, 5% Tween 80, 65% D5W, 14 mg/mL
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
ABT-751 is a cytoskeletal signaling inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of various cancers, including non-small cell lung cancer and others.
Storage
Store at -20ºC, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.